Blanket Purchase Agreement HT001415A0024
Award Date 1/9/15
Last Date to Order 1/14/20
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- The government has awarded a Blanket Purchase Agreement (BPA) to Nephron Sterile Compounding Center LLC, a woman-owned limited liability company, to provide pharmaceutical products and supplies to the Defense Health Agency (DHA). The BPA has a ceiling value of $4,000,000 and a period of performance through March 31, 2025. Under this BPA, Nephron has received two specific task orders to date. The first is a $20,625 firm fixed price award for various injectable pharmaceutical products including...
- The Defense Health Agency awarded a blanket purchase agreement to The Compounding Center Inc. to provide various pharmaceutical supplies and compounded medications. Under four firm fixed price call contracts valued between $25,000 to $150,000 placed against the agreement, the contractor will deliver shortage pharmaceuticals, compounded drugs, and chemical compounds to Walter Reed National Military Medical Center in Bethesda, Maryland. Performance is scheduled to take place through various...
- Golden State Medical Supply, Inc. has been awarded a multiple-award Federal Supply Schedule contract under the General Services Administration's Pharmaceuticals and Drugs program (FSS-61-IB) to supply drugs, pharmaceuticals, and hematology-related products to the Veterans Integrated Service Network 12 (VISN 12), the Department of Veterans Affairs' civilian healthcare funding entity. The contract, awarded on June 15, 2023, with an ultimate completion date of June 14, 2028, carries a ceiling value...
- Prasco, LLC, a pharmaceutical manufacturer and distributor headquartered in Mason, Ohio, was awarded a single-award Indefinite Delivery Contract (IDC) by the U.S. Medical Supply Chain on June 5, 2024, with a ceiling value of $31.7 million and a performance period extending through June 4, 2034. This defense-aligned contract establishes a framework for the supply of pharmaceutical and medical products to federal agencies, with no set-aside designation applied. The contract is executed under the...
- ASE Direct, Inc., a Service-Disabled Veteran-Owned Small Business headquartered in Brentwood, Tennessee, was awarded a single-award Blanket Purchase Agreement by the Department of Veterans Affairs Veterans Integrated Service Network 1 on November 1, 2021, with a ceiling value of $50.1 million and a period of performance extending through October 31, 2026. The contract establishes ASE Direct as a prime vendor under the Medical/Surgical Prime Vendor Program to supply an estimated 75,000 types of...
- Specgx LLC, operating as Mallinckrodt Pharmaceuticals and based in Webster Groves, Missouri, was awarded a single-award Indefinite Delivery Contract by the Defense Logistics Agency on September 27, 2024, with a ceiling value of $5.89 million and an ultimate completion date of September 26, 2029. This contract establishes Specgx as a national supply source for Methylphenidate HCL immediate-release tablets in 5 milligram, 10 milligram, and 20 milligram formulations in 100-count bottles. The...
- This Blanket Purchase Agreement, awarded on February 7, 2023, by the National Acquisition Center to Hikma Pharmaceuticals USA Inc. (formerly West-Ward Pharmaceuticals) with a ceiling value of $38.5 million, provides a single-award indefinite delivery vehicle for the procurement of sodium oxybate through December 17, 2025. No small business set-aside was utilized for this award. Sodium oxybate, marketed under the brand name XYREM, is a controlled pharmaceutical product used primarily in the...
- Actelion Pharmaceuticals US, Inc. has been awarded a Federal Supply Schedule (FSS-61-IB) contract for Pharmaceuticals and Drugs valued at $219.1 million with a period of performance from August 1, 2024, through July 31, 2029. This multiple-award indefinite delivery vehicle, funded by the Department of Veterans Affairs through Veterans Integrated Service Network 12, establishes a streamlined procurement framework enabling federal healthcare institutions to acquire specialized pharmaceutical...
- Marlex Pharmaceuticals Inc., a Delaware-based minority-owned small disadvantaged business, was awarded a single-award Indefinite Delivery Contract valued at $9,215,304.68 by the Medical Supply Chain (Defense Logistics Agency Troop Support Medical) on July 9, 2020, with an ultimate completion date of July 9, 2030. The contract encompasses the manufacture and distribution of generic pharmaceutical products in tablet form to support federal healthcare systems serving military personnel, veterans,...
- JRS Pharma LP, a pharmaceutical excipient manufacturer based in Patterson, New York, was awarded a single-award Indefinite Delivery Contract by the Department of Veterans Affairs Veterans Health Administration, Veterans Integrated Service Network 22, effective December 1, 2022, through November 30, 2026, with a ceiling value of $247,009.80. The contract procures PROSOLV EASYTAB SP, a pharmaceutical excipient used as an inactive ingredient in tablet formulation and drug delivery systems. No...
- HT001415A0024Blanket Purchase Agreement
- 22Federal Contract Awards
PHARMACEUTICAL SHORTAGE SUPPLIES
Posted 1/15/15
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00002 | Other Administrative Action | $0 | 1/8/18 | |
| P00001 | Other Administrative Action | $0 | 8/25/15 | |
| Not listed | Not listed | $0 | 1/15/15 |
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
BPA Call HT001415A0024-0005 | The Compounding Center Inc. | $300.0k | 10/19/15 | 9/30/16 | 11/10/15 | |
BPA Call HT001415A0024-HT001418F0289 | The Compounding Center Inc. | $250.0k | 6/27/18 | 9/30/18 | 11/1/18 | |
BPA Call HT001415A0024-HT001418F0222 | The Compounding Center Inc. | $25.0k | 5/8/18 | 9/30/18 | 5/15/18 | |
BPA Call HT001415A0024-0008 | The Compounding Center Inc. | $400.0k | 6/24/16 | 9/30/16 | 6/24/16 | |
BPA Call HT001415A0024-0010 | The Compounding Center Inc. | $650.0k | 10/6/16 | 9/30/17 | 11/1/16 |